BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 26688348)

  • 1. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation.
    Basil MC; Levy BD
    Nat Rev Immunol; 2016 Jan; 16(1):51-67. PubMed ID: 26688348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation.
    Duvall MG; Bruggemann TR; Levy BD
    Mol Aspects Med; 2017 Dec; 58():44-56. PubMed ID: 28455109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.
    Rasquel-Oliveira FS; Silva MDVD; Martelossi-Cebinelli G; Fattori V; Casagrande R; Verri WA
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections.
    Jordan PM; Werz O
    FEBS J; 2022 Jul; 289(14):4212-4227. PubMed ID: 34741578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting the pro-resolving actions of glucocorticoid-induced proteins Annexin A1 and GILZ in infectious diseases.
    Vago JP; Tavares LP; Riccardi C; Teixeira MM; Sousa LP
    Biomed Pharmacother; 2021 Jan; 133():111033. PubMed ID: 33378946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of interleukin-37 in infectious diseases.
    Allam G; Gaber AM; Othman SI; Abdel-Moneim A
    Int Rev Immunol; 2020; 39(1):3-10. PubMed ID: 31633447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence.
    Thornton JM; Yin K
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
    Zahoor I; Giri S
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
    Serhan CN; Chiang N; Dalli J
    Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Inflammation to Resolution: Specialized Pro-resolving Mediators in Posttraumatic Osteoarthritis.
    Leite CBG; Merkely G; Charles JF; Lattermann C
    Curr Osteoporos Rep; 2023 Dec; 21(6):758-770. PubMed ID: 37615856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.
    Tato CM; Hunter CA
    Infect Immun; 2002 Jul; 70(7):3311-7. PubMed ID: 12065467
    [No Abstract]   [Full Text] [Related]  

  • 13. Quenching the fires: Pro-resolving mediators, air pollution, and smoking.
    Thatcher TH; Woeller CF; McCarthy CE; Sime PJ
    Pharmacol Ther; 2019 May; 197():212-224. PubMed ID: 30759375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid mediators in neutrophil biology: inflammation, resolution and beyond.
    Ghodsi A; Hidalgo A; Libreros S
    Curr Opin Hematol; 2024 Jul; 31(4):175-192. PubMed ID: 38727155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.
    Recchiuti A; Mattoscio D; Isopi E
    Front Pharmacol; 2019; 10():252. PubMed ID: 31001110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized pro-resolving mediators in renal fibrosis.
    Brennan EP; Cacace A; Godson C
    Mol Aspects Med; 2017 Dec; 58():102-113. PubMed ID: 28479307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments of specialized pro-resolving mediators in periodontitis.
    Liu YC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators.
    Tavares LP; Nijmeh J; Levy BD
    Exp Biol Med (Maywood); 2023 Oct; 248(19):1635-1644. PubMed ID: 37837390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
    Tang S; Wan M; Huang W; Stanton RC; Xu Y
    Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?
    Dalli J
    Mol Aspects Med; 2017 Dec; 58():12-20. PubMed ID: 28365269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.